-
Je něco špatně v tomto záznamu ?
Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge
H. Stenberg, R. Chan, K. Abd-Elaziz, A. Pelgröm, K. Lammering, G. Kuijper-De Haan, E. Weersink, R. Lutter, AH. Zwinderman, F. de Jongh, Z. Diamant
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
Foresee Pharmaceuticals
NLK
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2019-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Health & Medicine (ProQuest)
od 2019-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
39941577
DOI
10.3390/jcm14030906
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: Small airway dysfunction (SAD) is associated with impaired asthma control, but small airway physiology is not routinely assessed in clinical practice. Previously, we demonstrated impulse oscillometry (IOS)-defined small airway dysfunction (SAD) in dual responders (DRs) upon bronchoprovocation with various allergens. Aim: To compare lung physiology using spirometry and IOS following bronchoprovocation with methacholine (M) and inhaled house dust mite (HDM) extract in corticosteroid-naïve asthmatic subjects. Methods: Non-smoking, clinically stable HDM-allergic asthmatic subjects (18-55 years, FEV1 > 70% of pred.) underwent an M and inhaled HDM challenge on two separate days. Airway response was measured by IOS and spirometry, until a drop in FEV1 ≥ 20% (PC20) from post-diluent baseline (M), and up to 8 h post-allergen (HDM). Early (EAR) and late asthmatic response (LAR) to HDM were defined as ≥20% and ≥15% fall in FEV1 from post-diluent baseline during 0-3 h and 3-8 h post-challenge, respectively. IOS parameters (Rrs5, Rrs20, Rrs5-20, Xrs5, AX, Fres) were compared between mono-responders (MRs: EAR only) and dual responders (EAR + LAR). Correlations between maximal % change from baseline after the two airway challenges were calculated for both FEV1 and IOS parameters. Results: A total of 47 subjects were included (11 MRs; 36 DRs). FEV1 % predicted did not differ between MR and DR at baseline, but DR had lower median PC20M (0.84 (range 0.07-7.51) vs. MR (2.15 (0.53-11.29)); p = 0.036). During the LAR, DRs had higher IOS values than MRs. For IOS parameters (but not for FEV1), the maximal % change from baseline following M and HDM challenge were correlated. PC20M was inversely correlated with the % change in FEV1 and the % change in Xrs5 during the LAR (r= -0.443; p = 0.0018 and r= -0.389; p = 0.0075, respectively). Conclusions: During HDM-induced LAR, changes in small airway physiology can be non-invasively detected with IOS and are associated with increased airway hyperresponsiveness and changes in small airway physiology during methacholine challenge. DRs have a small airways phenotype, which reflects a more advanced airway disease.
Lung Function Centre O2CO2 2582 EZ The Hague The Netherlands
QPS NL 9713 AG Groningen The Netherlands
School of Medicine University of Dundee Dundee DD1 9SY UK
University Clinic Primary Care Skåne 29189 Kristianstad Region Skåne Sweden
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008535
- 003
- CZ-PrNML
- 005
- 20250422095721.0
- 007
- ta
- 008
- 250408s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jcm14030906 $2 doi
- 035 __
- $a (PubMed)39941577
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Stenberg, Henning $u Center for Primary Health Care Research, Department of Clinical Sciences, Malmö, Lund University, 21428 Malmö, Sweden $u University Clinic Primary Care Skåne, 29189 Kristianstad, Region Skåne, Sweden $1 https://orcid.org/0000000269593380
- 245 10
- $a Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge / $c H. Stenberg, R. Chan, K. Abd-Elaziz, A. Pelgröm, K. Lammering, G. Kuijper-De Haan, E. Weersink, R. Lutter, AH. Zwinderman, F. de Jongh, Z. Diamant
- 520 9_
- $a Background: Small airway dysfunction (SAD) is associated with impaired asthma control, but small airway physiology is not routinely assessed in clinical practice. Previously, we demonstrated impulse oscillometry (IOS)-defined small airway dysfunction (SAD) in dual responders (DRs) upon bronchoprovocation with various allergens. Aim: To compare lung physiology using spirometry and IOS following bronchoprovocation with methacholine (M) and inhaled house dust mite (HDM) extract in corticosteroid-naïve asthmatic subjects. Methods: Non-smoking, clinically stable HDM-allergic asthmatic subjects (18-55 years, FEV1 > 70% of pred.) underwent an M and inhaled HDM challenge on two separate days. Airway response was measured by IOS and spirometry, until a drop in FEV1 ≥ 20% (PC20) from post-diluent baseline (M), and up to 8 h post-allergen (HDM). Early (EAR) and late asthmatic response (LAR) to HDM were defined as ≥20% and ≥15% fall in FEV1 from post-diluent baseline during 0-3 h and 3-8 h post-challenge, respectively. IOS parameters (Rrs5, Rrs20, Rrs5-20, Xrs5, AX, Fres) were compared between mono-responders (MRs: EAR only) and dual responders (EAR + LAR). Correlations between maximal % change from baseline after the two airway challenges were calculated for both FEV1 and IOS parameters. Results: A total of 47 subjects were included (11 MRs; 36 DRs). FEV1 % predicted did not differ between MR and DR at baseline, but DR had lower median PC20M (0.84 (range 0.07-7.51) vs. MR (2.15 (0.53-11.29)); p = 0.036). During the LAR, DRs had higher IOS values than MRs. For IOS parameters (but not for FEV1), the maximal % change from baseline following M and HDM challenge were correlated. PC20M was inversely correlated with the % change in FEV1 and the % change in Xrs5 during the LAR (r= -0.443; p = 0.0018 and r= -0.389; p = 0.0075, respectively). Conclusions: During HDM-induced LAR, changes in small airway physiology can be non-invasively detected with IOS and are associated with increased airway hyperresponsiveness and changes in small airway physiology during methacholine challenge. DRs have a small airways phenotype, which reflects a more advanced airway disease.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chan, Rory $u School of Medicine, University of Dundee, Dundee DD1 9SY, UK
- 700 1_
- $a Abd-Elaziz, Khalid $u Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands $1 https://orcid.org/0000000209644940
- 700 1_
- $a Pelgröm, Arjen $u Department of Pulmonary Medicine, Amsterdam University Medical Centre, 1007 MB Amsterdam, The Netherlands $1 https://orcid.org/0009000047165150
- 700 1_
- $a Lammering, Karin $u Lung Function Centre O2CO2, 2582 EZ The Hague, The Netherlands
- 700 1_
- $a Kuijper-De Haan, Gerda $u QPS-NL, 9713 AG Groningen, The Netherlands
- 700 1_
- $a Weersink, Els $u Department of Pulmonary Medicine, Amsterdam University Medical Centre, 1007 MB Amsterdam, The Netherlands
- 700 1_
- $a Lutter, René $u Department of Pulmonary Medicine, Amsterdam University Medical Centre, 1007 MB Amsterdam, The Netherlands
- 700 1_
- $a Zwinderman, Aeilko H $u Department of Epidemiology and Data Sciences, Amsterdam University Medical Centre, 1105 AZ Amsterdam, The Netherlands
- 700 1_
- $a de Jongh, Frans $u Department of Pulmonary Medicine, Amsterdam University Medical Centre, 1007 MB Amsterdam, The Netherlands $1 https://orcid.org/0000000260527504
- 700 1_
- $a Diamant, Zuzana $u Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands $u Department of Microbiology Immunology & Transplantation, Catholic University of Leuven, 3000 Leuven, Belgium $u Department of Respiratory Medicine, First Faculty of Medicine, Thomayer Hospital, Charles University, 12108 Prague, Czech Republic
- 773 0_
- $w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 14, č. 3 (2025)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39941577 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20250422095722 $b ABA008
- 999 __
- $a ok $b bmc $g 2306409 $s 1245610
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 14 $c 3 $e 20250130 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
- GRA __
- $p Foresee Pharmaceuticals
- LZP __
- $a Pubmed-20250408